Apyx Medical Corp — Form 8-K
Filed August 7, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 32/100
What the filing says
Apyx Medical adopted a new 2026 Share Incentive Plan authorizing 4,000,000 shares for grants of options and restricted stock to key employees, outside directors, and consultants. The plan permits the committee broad discretion over vesting, exercise prices, and award terms, with a 10-year term from shareholder approval. No specific grants, recipients, or dollar amounts were disclosed in this filing.
Why this rating
4M shares at ~$79.8M market cap represents ~5% dilution headroom—material but routine equity plan renewal. No grants announced; standard boilerplate governance.
See more from August 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.